Products for Research Use Only

N6- (4-Hydroxybenzyl) adenosine

CAT: 0804-HY-18775-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-18775-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
N6- (4-Hydroxybenzyl) adenosine is a inhibitor of platelet aggregation induced in vitro by collagen and their activity range was demonstrated (IC50: 6.77-141 μM) . IC50 value: 6.77-141 μM Target: P2Y12receptor Anti-aggregation activity of N6- (4-Hydroxybenzyl) adenosine could involve an interaction with the P2Y12receptor binding site.
CAS Number
110505-75-4
Product Name Alternative
Para-topolin riboside
UNSPSC
12352005
Target
P2Y Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/N6-_4-Hydroxybenzyl_adenosine.html
Purity
99.96
Solubility
DMSO : ≥ 100 mg/mL|H2O : < 0.1 mg/mL (ultrasonic)
Smiles
OC[C@@H]1[C@H]([C@H]([C@H](N2C=NC3=C2N=CN=C3NCC4=CC=C(O)C=C4)O1)O)O
Molecular Formula
C17H19N5O5
Molecular Weight
373.36
References & Citations
[1]Vistoli G, et al. Naturally occurring N (6) -substituted adenosines (cytokinin ribosides) are in vitro inhibitors of platelet aggregation: an in silico evaluation of their interaction with the P2Y (12) receptor. Bioorg Med Chem Lett. 2014 Dec 15;24 (24) :5652-5655.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported